Clubs How It Works

Markets Markets News MakklerAI My Portfolio · Pro

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

MakklerPRO About Us

Log In Get Started Free

Overview Stocks Crypto Currencies Commodities ETFs Options My watchlist

Makkler App

Faster and clearer

6785 Stock Price and Chart - Alar Pharmaceuticals Inc | Makkler

Overview/Stocks/6785

Alar Pharmaceuticals Inc 6785

TPEX · Taiwan · Health Technology

TWD 94.70-0.60 (-0.63%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Overview Financials Analysis Earnings Dividends Technicals Historical data News

Prices may be delayed and are for informational purposes only - not investment advice.

My Portfolio · Pro

Makkler vs. eToro

Makkler vs. Skool

Makkler vs. YouTube

Get Started Free

The portfolio-sharing platform connecting finance content creators with an audience that wants to learn.

Theme

Platform

Clubs Markets Markets News MakklerPRO Makkler Token How It Works Become a Creator

Compare

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

Company

About Us Contact

Legal

Terms of Service Privacy Policy Data Protection Notice Risk Disclosure Payment Policy

© 2026 Makkler. All rights reserved. Content on this platform does not constitute investment advice.

-43.29% · 6MFull-screen chart

TWD 183.50TWD 90.70

Apr 2, 2026Oct 2, 2026

Open TWD 95.10High TWD 95.40Low TWD 94.20Close TWD 94.70Volume 34.79K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: TWD 95.30
Day range: TWD 94.20 – TWD 95.40
52-week range: TWD 90.60 – TWD 317.00
Volume: 34.79K
Market cap: TWD 6.35B
Dividend yield (annualized): 0.11%
Next earnings date: 2026-11-05
Avg. volume (1Y): 156.69K

Performance

1 week

-1.56%

1 month

+3.84%

3 months

-23.55%

6 months

-48.34%

Year to date

-69.32%

1 year

-66.50%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Taiwan
Exchange: TPEX
Shares outstanding: 66.80M
Employees: 32
ISIN: TW0006785009
Beta: 0.33

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceApr 06, 2026

Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression

Alar Pharmaceuticals Inc. (Alar, TPEx:6785), a clinical-stage biopharmaceutical company focused on developing long-acting injectables (LAIs), today announced the positive results from its phase 1 clinical study of ALA-3000, a proprietary long-acting, sustained-release ketamine injection for treatment-resistant depression (TRD). This randomized, double-blind, placebo-controlled, multiple-dose first-in-human study evaluated the subcutaneous (SC) administration of ALA-3000 in combination with a sta

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.